Geneva, Jan. 12 -- International Clinical Trials Registry received information related to the study (NCT07310862) titled 'Virtual Reality - Gamma Sensory Stimulation for Improving Fatigue in People With Multiple Sclerosis' on Dec. 16, 2025.
Study Type: Interventional
Study Design:
Allocation: Randomized. Intervention model: Parallel Assignment. Primary purpose: Treatment. Masking: Quadruple (Participant, Care Provider, Investigator, Outcomes Assessor).
Primary Sponsor: Clarity Health Technologies, Inc
Condition:
Multiple Sclerosis
Intervention:
Device: Virtual Reality Gamma Sensory Stimulation
Recruitment Status: Not recruiting
Phase: N/A
Date of First Enrollment: February 1, 2026
Target Sample Size: 30
Countries of Recru...